Stock listing

NASDAQ:PRVB Provention Bio Inc Stock

Follow Provention Bio Inc into a list and get an email when it puts out news.

Last close · NASDAQ:PRVB

$24.98 USD

Close on Apr 27, 2023 · No longer trades

Jul 24, 2018 to last close +419.3% · weekly closes, Jul 24, 2018 – Apr 27, 2023
Lowest – highest close
$1.73 – $24.98 USDSince Jul 24, 2018 · lowest Dec 28, 2018 · highest Apr 26, 2023

Delisted NASDAQ:PRVB no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:PRVB
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Provention Bio Inc on 6ix

Calls
7 calls with a replay · 7 with a transcript · latest Nov 3, 2022
Decks
2 decks · latest Jun 15, 2020

Events

CallWhenStatus
Provention Bio (PRVB) Q3 2022 Earnings CallThu, Nov 03, 2022 · 9:00 AM ETReplay
Provention Bio (PRVB) Q2 2022 Earnings CallThu, Aug 04, 2022 · 8:00 AM ETReplay
Provention Bio (PRVB) Q1 2022 Earnings CallThu, May 05, 2022 · 8:00 AM ETReplay
Provention Bio (PRVB) Q4 2021 Earnings CallThu, Feb 24, 2022 · 8:00 AM ETReplay
Provention Bio (PRVB) Q3 2021 Earnings CallThu, Nov 04, 2021 · 8:00 AM ETReplay
Provention Bio (PRVB) Q2 2021 Earnings CallThu, Aug 05, 2021 · 8:00 AM ETReplay
Provention Bio (PRVB) Q1 2021 Earnings CallThu, May 06, 2021 · 8:00 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (June 2020)Investor deck34 slidesJun 15, 2020
Corporate Update (June 2019)Corporate update18 slidesJun 10, 2019

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Nancy J. Wysenski
Other companies: Cytokinetics, Incorporated (Director · Since at least Nov 20, 2020); Dova Pharmaceuticals Inc (Director · Jun 25, 2018 – Nov 12, 2019 · Past); Inovio Pharmaceuticals, Inc. (Director · Mar 4, 2015 – May 13, 2016 · Past); Tetraphase Pharmaceuticals Inc (Director · Mar 10, 2014 – Jun 10, 2019 · Past); Alkermes plc (Director · May 15, 2013 – Jul 7, 2023 · Past); Vertex Pharmaceuticals Incorporated (EVP, Chief Commercial Officer · Dec 9, 2009 – May 14, 2012 · Past); Indevus Pharmaceuticals Inc (Director · Feb 23, 2009 – Feb 23, 2009 · Past); North American Scientific Inc (Director · May 3, 2006 – Apr 29, 2008 · Past)
Director · May 19, 2020 – Apr 27, 2023 · Past
Anthony DiGiandomenico
Other companies: Illumination Acquisition Corp I (Director · Since at least Feb 26, 2026); ClearSign Technologies Corporation (Director · Since at least May 22, 2025); eXoZymes Inc. (Board Member · Since at least Nov 8, 2024); MDB Capital Holdings, LLC (Co-Founder, Head of New Venture Discovery · Since at least Jul 25, 2023); ENDRA Life Sciences Inc. (Director · Since at least May 8, 2017); Cue Biopharma, Inc. (Director · Dec 18, 2017 – Jan 2, 2019 · Past); Charlie's Holdings, Inc. (Director · Aug 4, 2006 – Aug 27, 2012 · Past)
Director · Jul 3, 2018 – May 15, 2020 · Past
Avery W Catlin
Other companies: Corbus Pharmaceuticals Holdings, Inc. (Director · Nov 24, 2014 – May 30, 2024 · Past); Celldex Therapeutics, Inc. (Sr. VP & CFO · Jan 6, 2006 – Sep 2, 2016 · Past)
Director · Sep 5, 2018 – Apr 27, 2023 · Past
Cameron Gray
Other companies: Cue Biopharma, Inc. (Director · Dec 18, 2017 – Jun 14, 2022 · Past); Endeavor IP Inc (CEO, CFO, Secretary, Treasurer, Director · May 13, 2013 – May 13, 2013 · Past)
Director · Jul 3, 2018 – Jul 19, 2018 · Past
Wayne Pisano
Other companies: Oncolytics Biotech Inc. (Director · Since at least Jun 26, 2025); Altimmune, Inc. (Director · Since at least Aug 30, 2018)
Director · Jul 3, 2018 – Apr 27, 2023 · Past
Eleanor Ramos
Other companies: Global Blood Therapeutics Inc (Chief Medical Officer · Aug 11, 2015 – Sep 29, 2016 · Past)
Chief Medical Officer · Jul 3, 2018 – Apr 27, 2023 · Past
Jason Hoitt
Other companies: Stoke Therapeutics, Inc. (Chief Patient Officer · Since at least Jun 18, 2025)
Chief Commercial Officer · Dec 8, 2022 – Apr 27, 2023 · Past
John Kenneth Jenkins
Other companies: Corbus Pharmaceuticals Holdings, Inc. (Director · Since at least Jun 5, 2018)
Director · Aug 10, 2020 – Apr 27, 2023 · Past
Justin Vogel
Other companies: Mistras Group Inc (Principal Accounting Officer · Sep 4, 2013 – Sep 4, 2013 · Past)
Chief Accounting Officer · Jan 3, 2023 – Apr 27, 2023 · Past
Thierry Chauche
Other companies: Sagimet Biosciences Inc. - Series A (Chief Financial Officer · Since at least May 6, 2024)
Chief Financial Officer · Dec 1, 2021 – Apr 27, 2023 · Past
All 16 people
PersonSeat
Andrew T DrechslerChief Financial Officer · Jun 24, 2019 – May 12, 2021 · Past
Ashleigh PalmerDirector and CEO · Jul 3, 2018 – Apr 27, 2023 · Past
Francisco LeonChief Scientific Officer · Jul 3, 2018 – Apr 27, 2023 · Past
Miyoko Christina YiChief Operations Officer · Dec 16, 2021 – Apr 27, 2023 · Past
Sarah O'BrienChief People Officer · Sep 15, 2022 – Jan 10, 2023 · Past
Sean M DohertyDirector · Sep 26, 2019 – May 17, 2022 · Past

Open People

Log in to ask 6ix AI your own questions about Provention Bio Inc.